| Name | Title | Contact Details |
|---|
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
B&D Consulting is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Infranco Moore Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Daxor Corporation is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in New York, NY. To find more information about Daxor Corporation, please visit www.daxor.com
Prairie North Health Region is a North Battleford, SK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.